Photodynamic therapy mediated by liposomal chloroaluminum-phthalocyanine induces necrosis in oral cancer cells

Journal of Biomaterials and Tissue Engineering

Volumn 3, Issue 1, 2013, Pages 148-156

  Longo, João Paulo Figueiró ^a   de Melo, Larissa Naves Duarte ^a   Mijan, Maitê Cevallos ^a   Valois, Caroline Rodrigues Alves ^a   Joanitti, Graziella Anselmo ^a   Simioni, Andreza Ribeiro ^b   Tedesco, Antonio Cláudio ^b   de Azevedo, Ricardo Bentes ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Liposomes; Necrosis; Photodynamic therapy; Phthalocyanines

Indexed keywords

CHLOROALUMINUM PHTHALOCYANINE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; FLOW CYTOMETRY; HISTOPATHOLOGY; IRRADIATION; MOUSE; MOUTH CANCER; NONHUMAN; PHOTODYNAMIC THERAPY; TUMOR GROWTH; TUMOR VOLUME;

EID: 84891603476     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2013.1070     Document Type: Article

References (30)

1. G. A. Colditz, T. A. Sellers, and E. Trapido, Epidemiology-identifying the causes and preventability of cancer? Nature Reviews Cancer 6, 75 (2005).
2. A. Sharwani, W. Jerjes, C. Hopper, M. P. Lewis, M. El-Maaytah, H. S. M. Khalil, A. J. MacRobert, and V. Salih, Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer. Archives of Oral Biology 51, 1104 (2006).
3. L. Balducci and W. B. Ershler, Cancer and ageing: A nexus at several levels. Nature Reviews Cancer 5, 655 (2005).
4. O. Bettendorf, J. Piffko, and A. Bankfalvi, Prognostic and predictive factors in oral squamous cell cancer: Important tools for planning individual therapy? Oral Oncology 40, 110 (2004).
5. C. Hopper, C. Niziol, and M. Sidhu, The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncology 40, 372 (2004).
6. M. Ochsner, Photophysical and photobiological processes in the photodynamic therapy of tumours. Journal of Photochemistry and Photobiology B: Biology 39, 1 (1997).
7. L. A. Muehlmann, G. A. Joanitti, J. R. Silva, J. P. F. Longo, and R. B. Azevedo, Liposomal photosensitizers: Potential platforms for anticancer photodynamic therapy. Brazilian Journal of Medical and Biological Research 44, 729 (2011).
8. R. D. Almeida, B. J. Manadas, A. P. Carvalho, and C. B. Duarte, Intracellular signaling mechanisms in photodynamic therapy. Biochimica et Biophysica Acta (BBA).-Reviews on Cancer 1704, 59 (2004).
9. R. R. Allison, G. H. Downie, R. Cuenca, X. H. Hu, C. J. H. Childs, and C. H. Sibata, Photosensitizers in clinical PDT. Photodiagnosis and Photodynamic Therapy 1, 27 (2004).
10. R. R. Allison, H. C. Mota, V. S. Bagnato, and C. H. Sibata, Bionanotechnology and photodynamic therapy-State of the art review. Photodiagnosis and Photodynamic Therapy 5, 19 (2008).
11. K. Ichikawa, T. Hikita, N. Maeda, S. Yonezawa, Y. Takeuchi, T. Asai, Y. Namba, and N. Oku, Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochimica et Biophysica Acta (BBA)-Biomembranes 1669, 69 (2005).
12. Y. Sadzuka, F. Iwasaki, I. Sugiyama, K. Horiuchi, T. Hirano, H. Ozawa, N. Kanayama, and N. Oku, Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization. Toxicology Letters 182, 110 (2008).
13. S. M. T. Nunes, F. S. Sguilla, and A. C. Tedesco, Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives. Brazilian Journal of Medical and Biological Research 37, 273 (2004).
14. I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods 139, 271 (1991).
15. J. P. F. Longo, S. P. Lozzi, A. R. Simioni, P. C. Morais, A. C. Tedesco, and R. B. Azevedo Photodynamic therapy with aluminum-chloro-phtalocyanine induces necrosis and vascular damage in mice tongue tumors. Journal of Photochemistry and Photobiology B: Biology 94, 143 (2009).
16. A. S. L. Derycke and P. A. M. de Witte, Liposomes for photodynamic therapy. Advanced Drug Delivery Reviews 56, 17 (2004).
17. M. A. Biel, Photodynamic therapy treatment of early oral and laryngeal cancers. Photochemistry and Photobiology 83, 1063 (2007).
18. I. Cecic and M. Korbelik, Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Letters 183, 43 (2002).
19. H. Nakaseko, M. Kobayashi, Y. Akita, Y. Tamada, and Y. Matsumoto, Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. British Journal of Dermatology 148, 122 (2003).
20. D. Mitton and R. Ackroyd, History of photodynamic therapy in Great Britain. Photodiagnosis and Photodynamic Therapy 2, 239 (2005).
21. C. Fabris, G. Valduga, G. Miotto, L. Borsetto, G. Jori, S. Garbisa, and S. Reddi, Photosensitization with zinc(II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Research 61, 7495 (2001).
22. E. C. C. Tapajós, J. P. Longo, A. R. Simioni, Z. G. M. Lacava, M. Santos, P. C. Morais, A. C. Tedesco, and R. B. Azevedo, In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncology 44, 1073 (2008).
23. S. L. Haywood-Small, D. I. Vernon, J. Griffiths, J. Schofield, and S. B. Brown, Phthalocyanine-mediated photodynamic therapy induces cell death and a G0/G1 cell cycle arrest in cervical cancer cells. Biochemical and Biophysical Research Communications 339, 569 (2006).
24. J. Mikeš, J. Kleban, V. Saková, V. Horváth, E. Jamborová, A. Vaculová, A. Kozubík, J. Hofmanová, and P. Fedorǒcko, Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin. Photochemical and Photobiological Sciences 6, 758 (2007).
25. L. Wyld, M. W. R. Reed, and N. J. Brown, Differential cell death response to photodynamic therapy is dependent on dose and cell type. British Journal of Cancer 84, 1384 (2001).
26. W. H. Boehncke, A. Rück, J. Naumann, W. Sterry, and R. Kaufmann, Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro. Lasers in Surgery and Medicine 19, 451 (1996).
27. A. P. Castano, P. Mroz, and M. R. Hamblin, Photodynamic therapy and anti-tumour immunity. Nature Reviews Cancer 6, 535 (2006).
28. C. Hopper, A. Kübler, H. Lewis, I. B. Tan, and G. Putnam, mTHPCmediated photodynamic therapy for early oral squamous cell carcinoma. International Journal of Cancer 111, 138 (2004).
29. A. S. Sobolev, D. A. Jans, and A. A. Rosenkranz, Targeted intracellular delivery of photosensitizers. Progress in Biophysics and Molecular Biology 73, 51 (2000).
30. G. M. Tozer, C. Kanthou, and B. C. Baguley, Disrupting tumour blood vessels. Nature Reviews Cancer 5, 423 (2005).